# Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System

Study · id `cardio:ct-nct01187368` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01187368](<https://clinicaltrials.gov/study/NCT01187368>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01187368

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 399 participants.

## Technical summary

Registry record NCT01187368. Randomized; no masking; primary purpose treatment. Start 2020-03-31 (actual); primary completion 2027-07-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 399 participants (planned count; ClinicalTrials.gov record NCT01187368, source copy `cardio:ctgov-nct01187368-2026-03-27`, retrieved 2026-10-26)
- Started: 2020-03-31 (actual) (ClinicalTrials.gov record NCT01187368, source copy `cardio:ctgov-nct01187368-2026-03-27`, retrieved 2026-10-26)
- Primary completion: 2027-07-31 (anticipated) (ClinicalTrials.gov record NCT01187368, source copy `cardio:ctgov-nct01187368-2026-03-27`, retrieved 2026-10-26)
- Completion: 2028-07-31 (anticipated) (ClinicalTrials.gov record NCT01187368, source copy `cardio:ctgov-nct01187368-2026-03-27`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01187368, source copy `cardio:ctgov-nct01187368-2026-03-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "SUSPENDED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01187368-2026-03-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System
- Acronym: COMPETENCE
- Condition: Heart Failure
- Intervention (Device): EVAHEART Left Ventricular Assist System (LVAS)
- Intervention (Device): HeartMate 3
- Lead sponsor: Evaheart, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: 9fd3acebc5fc22e5f777fa7b83d8468aedae6f134d6f42328d948613923d1e7b
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
